Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion type Assertion NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_head.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion description "[The mammalian target of rapamycin, which is a sensor of the mitochondrial transmembrane potential, has been successfully targeted for treatment of SLE with rapamycin or sirolimus in both patients and animal models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion evidence source_evidence_literature NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion SIO_000772 20014960 NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion wasDerivedFrom befree-20150227 NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.
- NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_assertion wasGeneratedBy ECO_0000203 NP411890.RAWM9WU5cmVfHUm9CbPJGL5AUJwgLqRREw-sRfU62S2-U130_provenance.